AAAAAA

   
Results: 1-10 |
Results: 10
Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats
Authors: Raasch, W Betge, S Dendorfer, A Bartels, T Dominiak, P
Citation: W. Raasch et al., Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats, J HYPERTENS, 19(10), 2001, pp. 1827-1833
Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation
Authors: Dendorfer, A Reissmann, S Wolfrum, S Raasch, W Dominiak, P
Citation: A. Dendorfer et al., Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation, HYPERTENSIO, 38(1), 2001, pp. 142-146
Interactions of ligands at angiotensin II-receptors and imidazoline receptors
Authors: Wethmar, U Raasch, W Dendorfer, A Dominiak, P
Citation: U. Wethmar et al., Interactions of ligands at angiotensin II-receptors and imidazoline receptors, JPN J PHARM, 85(2), 2001, pp. 167-174
Biological significance of agmatine, an endogenous ligand at imidazoline binding sites
Authors: Raasch, W Schafer, U Chun, J Dominiak, P
Citation: W. Raasch et al., Biological significance of agmatine, an endogenous ligand at imidazoline binding sites, BR J PHARM, 133(6), 2001, pp. 755-780
Ramipril increases the protein level of skeletal muscle IRS-1 and alters protein tyrosine phosphatase activity in spontaneously hypertensive rats
Authors: Krutzfeldt, J Raasch, W Klein, HH
Citation: J. Krutzfeldt et al., Ramipril increases the protein level of skeletal muscle IRS-1 and alters protein tyrosine phosphatase activity in spontaneously hypertensive rats, N-S ARCH PH, 362(1), 2000, pp. 1-6
Positive inotropic effects of imidazoline derivatives are not mediated viaimidazoline binding sites but alpha(1)-adrenergic receptors
Authors: Raasch, W Chun, KRJ Dendorfer, A Dominiak, P
Citation: W. Raasch et al., Positive inotropic effects of imidazoline derivatives are not mediated viaimidazoline binding sites but alpha(1)-adrenergic receptors, JPN J PHARM, 84(1), 2000, pp. 1-6
In vitro and in vivo long term release of apomorphine from polymer matrices
Authors: Raasch, W Slotty, C Dominiak, P
Citation: W. Raasch et al., In vitro and in vivo long term release of apomorphine from polymer matrices, JPN J PHARM, 84(1), 2000, pp. 36-43
Mechanisms of bradykinin-induced catecholamine release in pithed spontaneously hypertensive rats
Authors: Dendorfer, A Fitschen, M Raasch, W Tempel, K Dominiak, P
Citation: A. Dendorfer et al., Mechanisms of bradykinin-induced catecholamine release in pithed spontaneously hypertensive rats, IMMUNOPHARM, 44(1-2), 1999, pp. 99-104
The lipophilic properties of angiotensin I-converting enzyme inhibitors donot influence their diffusion through cultured endothelium
Authors: Raasch, W Dendorfer, A Ball, B Dominiak, P
Citation: W. Raasch et al., The lipophilic properties of angiotensin I-converting enzyme inhibitors donot influence their diffusion through cultured endothelium, JPN J PHARM, 81(4), 1999, pp. 346-352
Microtiter well assays for protein tyrosine phosphatase activities directed against phosphorylated insulin receptor or insulin receptor substrate-1
Authors: Krutzfeldt, J Grunweller, A Raasch, W Drenckhan, M Klein, HH
Citation: J. Krutzfeldt et al., Microtiter well assays for protein tyrosine phosphatase activities directed against phosphorylated insulin receptor or insulin receptor substrate-1, ANALYT BIOC, 271(1), 1999, pp. 97-99
Risultati: 1-10 |